TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TerSera Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11058
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of allergy and immunology, central nervous system disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies and urology and women’s health, among others. TerSera Therapeutics spans its expertise in all phases of pre-clinical and clinical development, lifecycle management and phase IV studies, delivery a comprehensive set of programs that go beyond the therapy. The company serves patients, partners and prescribers across North America. TerSera Therapeutics is headquartered in Lake Forest, Illinois, the US.

TerSera Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
TerSera Therapeutics to Acquire Prialt from Jazz Pharma for USD80 Million 10
TerSera Therapeutics to Acquire North American Rights to Varubi from TESARO 11
Licensing Agreements 12
TerSera Therapeutics Enters into Licensing Agreement with AstraZeneca for Zoladex 12
TerSera Therapeutics LLC – Key Competitors 13
TerSera Therapeutics LLC – Key Employees 14
TerSera Therapeutics LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TerSera Therapeutics LLC, Deals By Therapy Area, 2012 to YTD 2018 8
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TerSera Therapeutics to Acquire Prialt from Jazz Pharma for USD80 Million 10
TerSera Therapeutics to Acquire North American Rights to Varubi from TESARO 11
TerSera Therapeutics Enters into Licensing Agreement with AstraZeneca for Zoladex 12
TerSera Therapeutics LLC, Key Competitors 13
TerSera Therapeutics LLC, Key Employees 14

List of Figures
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TerSera Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Merck & Co., Inc.:企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Symbiotec Pharmalab Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Pilatus Group:企業の戦略・SWOT・財務情報
    Pilatus Group - Strategy, SWOT and Corporate Finance Report Summary Pilatus Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • HSBC Trinkaus & Burkhardt Private Banking:企業の戦略・SWOT・財務情報
    HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Arma Global Corporation:企業の戦略・SWOT・財務分析
    Arma Global Corporation - Strategy, SWOT and Corporate Finance Report Summary Arma Global Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • ICICI Bank Ltd:企業のM&A・事業提携・投資動向
    ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Capital Power Corporation (CPX)-エネルギー分野:企業M&A・提携分析
    Summary Capital Power Corporation (CPC) is a power producer that develops, acquires, operates, optimizes, and builds power generation facilities. It generates electricity from energy-efficient technology, lower-carbon fuel, and renewable sources using a range of energy sources. The company owns supe …
  • Legend Holdings Corporation (3396):企業の財務・戦略的SWOT分析
    Legend Holdings Corporation (3396) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務分析
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Uflex Limited:企業の戦略・SWOT・財務情報
    Uflex Limited - Strategy, SWOT and Corporate Finance Report Summary Uflex Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SKYCITY Entertainment Group Ltd:戦略・SWOT・企業財務分析
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • X-ELIO Energy SL:電力:M&Aディール及び事業提携情報
    Summary X-ELIO Energy SL (X-ELIO), formerly Gestamp Solar, a subsidiary of Corporacion Gestamp S.L. is an alternative energy company that operates utility scale photovoltaic power plants. The company constructs, designs, installs, develops, and maintains solar photovoltaic plants. Its development, c …
  • Bio-Modeling Systems SAS-製薬・医療分野:企業M&A・提携分析
    Summary Bio-Modeling Systems SAS (BM Systems) is a mechanism based medicine company which discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as Computer-Assisted Deductive Integration (CADI), which i …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆